CJC-1295 (with DAC)
Shop CJC-1295 (with DAC)Also called: CJC-1295 DAC, CJC-1295 DAC Recovery & Sleep Protocol
CJC-1295 (with DAC) is a man-made substance that acts like a chemical messenger in the body.
Building Blocks
CJC-1295 (with DAC) in Stacks & Blends
CJC-1295 (with DAC) is one of the building blocks in this blend or stack people actually buy:
Natural growth-hormone release — recovery, body composition, sleep
Paired with Ipamorelin
Established GH blend
Benefits
What CJC-1295 (with DAC) Helps With
The benefits people report — backed by research.
Glycemic & metabolic (1)
More reported benefits (1)
Free: The Peptide Stack Cheat-Sheet
See where CJC-1295 (with DAC) fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
Get CJC-1295 (with DAC)
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
News
Latest on CJC-1295 (with DAC)
Dated, sourced reporting that mentions CJC-1295 (with DAC).
CNN investigation: wellness influencers drive boom in unapproved "research-use-only" peptides
A November 2025 CNN report documents how celebrities and wellness influencers are fueling mass consumer use of unapproved peptides like BPC-157, TB-500, ipamorelin, and CJC-1295, many sold with a "for research use only" label that lawyers and regulators describe as a loophole to evade FDA oversight. Health Secretary Robert F. Kennedy Jr. has vowed to end the agency's "war on peptides," while named sellers such as biohacker Gary Brecka market injectable vials for $350 to $600 each. Independent experts — including Scripps' Dr. Eric Topol and UC Davis biologist Paul Knoepfler — stress that none of these compounds have passed adequate clinical trials and that "research-grade" powders often contain contaminants. BPC-157 and TB-500 are also banned by international sports authorities as doping substances.
FDA fires warning letters at online peptide vendors selling BPC-157, TB-500 as drugs
Across 2025-2026 the FDA's Office of Compliance issued a string of warning letters to internet peptide retailers - including USApeptide.com (February 2025), Gram Peptides (March 2026), and Wholesale Peptide (June 2026) - alleging they are selling unapproved new drugs in violation of Section 505(a) of the FD&C Act. The letters single out products marketed for healing, recovery, and research that the agency says carry disease-treatment claims triggering drug status. Named substances include BPC-157, TB-500 (thymosin beta-4), CJC-1295, ipamorelin, and GHK-Cu. The enforcement runs in tension with the July 2026 PCAC vote recommending several of these same peptides for the 503A compounding list, but legally the two tracks are separate.
Wondering how CJC-1295 (with DAC) pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →